{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:08:44Z","timestamp":1789610924468,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,4,21]]},"DOI":"10.1038\/onc.2015.264","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T14:07:24Z","timestamp":1436191644000},"page":"2052-2061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["BIRC5\/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma"],"prefix":"10.1038","volume":"35","author":[{"given":"J","family":"Hagenbuchner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Kiechl-Kohlendorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Obexer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Ausserlechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"key":"BFonc2015264_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/sj.onc.1203358","volume":"19","author":"A Islam","year":"2000","unstructured":"Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E et al. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 2000; 19: 617\u2013623.","journal-title":"Oncogene"},{"key":"BFonc2015264_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/76838","volume":"7","author":"MA Verdecia","year":"2000","unstructured":"Verdecia MA, Huang Hk, Dutil E, Kaiser DA, Hunter T, Noel JP . Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Mol Biol 2000; 7: 602\u2013608.","journal-title":"Nat Struct Mol Biol"},{"key":"BFonc2015264_CR3","doi-asserted-by":"publisher","first-page":"10100","DOI":"10.1158\/0008-5472.CAN-06-1684","volume":"66","author":"F Morgillo","year":"2006","unstructured":"Morgillo F, Woo JK, Kim ES, Hong WK, Lee HY . Heterodimerization of insulin-like growth factor receptor\/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib. Cancer Res 2006; 66: 10100\u201310111.","journal-title":"Cancer Res"},{"key":"BFonc2015264_CR4","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1073\/pnas.072586399","volume":"99","author":"J Tran","year":"2002","unstructured":"Tran J, Master Z, Yu JL, Rak J, Dumont DJ, Kerbel RS . A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci 2002; 99: 4349\u20134354.","journal-title":"Proc Natl Acad Sci"},{"key":"BFonc2015264_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/70487","volume":"23","author":"VE Velculescu","year":"1999","unstructured":"Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C et al. Analysis of human transcriptomes. Nat Genet 1999; 23: 387\u2013388.","journal-title":"Nat Genet"},{"key":"BFonc2015264_CR6","doi-asserted-by":"publisher","first-page":"24721","DOI":"10.1074\/jbc.M603175200","volume":"281","author":"BH Kang","year":"2006","unstructured":"Kang BH, Altieri DC . Regulation of Survivin Stability by the Aryl Hydrocarbon Receptor-interacting Protein. J Biol Chem 2006; 281: 24721\u201324727.","journal-title":"J Biol Chem"},{"key":"BFonc2015264_CR7","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1172\/JCI200422222","volume":"114","author":"T Dohi","year":"2004","unstructured":"Dohi T, Beltrami E, Wall NR, Plescia J, Altieri DC . Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 2004; 114: 1117\u20131127.","journal-title":"J Clin Invest"},{"key":"BFonc2015264_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/sj.embor.7400795","volume":"7","author":"BPS Eckelman","year":"2006","unstructured":"Eckelman BPS . Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 2006; 7: 988\u2013994.","journal-title":"EMBO Rep"},{"key":"BFonc2015264_CR9","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1091\/mbc.e08-07-0699","volume":"20","author":"P Obexer","year":"2009","unstructured":"Obexer P, Hagenbuchner J, Unterkircher T, Sachsenmaier N, Seifarth C, Bock G et al. Repression of BIRC5\/survivin by FOXO3\/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis. Mol Biol Cell 2009; 20: 2041\u20132048.","journal-title":"Mol Biol Cell"},{"key":"BFonc2015264_CR10","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1038\/onc.2012.500","volume":"32","author":"J Hagenbuchner","year":"2013","unstructured":"Hagenbuchner J, Kuznetsov AV, Obexer P, Ausserlechner MJ . BIRC5\/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion\/fission machinery. Oncogene 2013; 32: 4748\u20134757.","journal-title":"Oncogene"},{"key":"BFonc2015264_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2014.07.013","volume":"35","author":"W Zhou","year":"2014","unstructured":"Zhou W, Yuan J . Necroptosis in health and diseases. Semin Cell Dev Biol 2014; 35: 14\u201323.","journal-title":"Semin Cell Dev Biol"},{"key":"BFonc2015264_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/auto.1.2.1738","volume":"1","author":"J Debnath","year":"2005","unstructured":"Debnath J, Baehrecke EH, Kroemer G . Does autophagy contribute to cell death? Autophagy 2005; 1: 66\u201374.","journal-title":"Autophagy"},{"key":"BFonc2015264_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/icb.2014.85","volume":"93","author":"D Denton","year":"2014","unstructured":"Denton D, Xu T, Kumar S . Autophagy as a pro-death pathway. Immunol Cell Biol 2014; 93: 35\u201342.","journal-title":"Immunol Cell Biol"},{"key":"BFonc2015264_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.1099993","volume":"306","author":"T Shintani","year":"2004","unstructured":"Shintani T, Klionsky DJ . Autophagy in health and disease: a double-edged sword. Science 2004; 306: 990\u2013995.","journal-title":"Science"},{"key":"BFonc2015264_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","volume":"18","author":"R Kang","year":"2011","unstructured":"Kang R, Zeh HJ, Lotze MT, Tang D . The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011; 18: 571\u2013580.","journal-title":"Cell Death Differ"},{"key":"BFonc2015264_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","volume":"122","author":"S Pattingre","year":"2005","unstructured":"Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N et al. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 2005; 122: 927\u2013939.","journal-title":"Cell"},{"key":"BFonc2015264_CR17","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1016\/j.febslet.2010.07.018","volume":"584","author":"TK Niu","year":"2010","unstructured":"Niu TK, Cheng Y, Ren X, Yang JM . Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis. FEBS Lett 2010; 584: 3519\u20133524.","journal-title":"FEBS Lett"},{"key":"BFonc2015264_CR18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3892\/or.2013.2242","volume":"29","author":"A Abe","year":"2012","unstructured":"Abe A, Kokuba H . Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin. Oncol Rep 2012; 29: 1333\u20131342.","journal-title":"Oncol Rep"},{"key":"BFonc2015264_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF . Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer 2013; 12: 152.","journal-title":"Mol Cancer"},{"key":"BFonc2015264_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1006\/excr.2002.5508","volume":"276","author":"R Stern","year":"2002","unstructured":"Stern R, Shuster S, Neudecker BA, Formby B . Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res 2002; 276: 24\u201331.","journal-title":"Exp Cell Res"},{"key":"BFonc2015264_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.11.032","volume":"1132","author":"X Wang","year":"2007","unstructured":"Wang X, Perez E, Liu R, Yan LJ, Mallet RT, Yang SH . Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res 2007; 1132: 1\u20139.","journal-title":"Brain Res"},{"key":"BFonc2015264_CR22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0959-8049(00)00400-7","volume":"37","author":"M De Lena","year":"2001","unstructured":"De Lena M, Lorusso V, Latorre A, Fanizza G, Gargano G, Caporusso L et al. Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study. Eur J Cancer 2001; 37: 364\u2013368.","journal-title":"Eur J Cancer"},{"key":"BFonc2015264_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00280-003-0724-7","volume":"53","author":"J Maher","year":"2004","unstructured":"Maher J, Krishan A, Lampidis T . Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother Pharmacol 2004; 53: 116\u2013122.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFonc2015264_CR24","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/pros.21172","volume":"70","author":"M Stein","year":"2010","unstructured":"Stein M, Lin H, Jeyamohan C, Dvorzhinski D, Gounder M, Bray K et al. Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate 2010; 70: 1388\u20131394.","journal-title":"Prostate"},{"issue":"10","key":"BFonc2015264_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/jop.12299","volume":"44","author":"Khadka Sachita","year":"2014","unstructured":"Sachita K, Yu HJ, Yun JW, Lee JS, Cho SD . YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines. J Oral Pathol Med 2014, e-pub ahead of print 5 December 2014 doi:10.1111\/jop.12299.","journal-title":"Journal of Oral Pathology & Medicine"},{"key":"BFonc2015264_CR26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.7150\/ijms.5547","volume":"10","author":"Y Cheng","year":"2013","unstructured":"Cheng Y, Diao DM, Zhang H, Zhang HF, Song YC, Dang C-X et al. Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis. Int J Med Sci 2013; 10: 634\u2013640.","journal-title":"Int J Med Sci"},{"key":"BFonc2015264_CR27","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.1158\/0008-5472.CAN-11-0759","volume":"71","author":"S Ram\u00edrez-Peinado","year":"2011","unstructured":"Ram\u00edrez-Peinado S, Alc\u00e1zar-Limones F, Lagares-Tena L, El Mjiyad N, Caro-Maldonado A, Tirado OM et al. 2-Deoxyglucose induces noxa-dependent apoptosis in alveolar rhabdomyosarcoma. Cancer Res 2011; 71: 6796\u20136806.","journal-title":"Cancer Res"},{"key":"BFonc2015264_CR28","doi-asserted-by":"publisher","first-page":"30387","DOI":"10.1074\/jbc.M113.490581","volume":"288","author":"S Ram\u00edrez-Peinado","year":"2013","unstructured":"Ram\u00edrez-Peinado S, Le\u00f3n-Annicchiarico CL, Galindo-Moreno J, Iurlaro R, Caro-Maldonado A, Prehn JH et al. Glucose-starved cells do not engage in prosurvival autophagy. J Biol Chem 2013; 288: 30387\u201330398.","journal-title":"J Biol Chem"},{"key":"BFonc2015264_CR29","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1038\/cddis.2013.149","volume":"4","author":"CY Huang","year":"2013","unstructured":"Huang CY, Kuo WT, Huang YC, Lee TC, Yu LCH . Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells. Cell Death Dis 2013; 4: e622.","journal-title":"Cell Death Dis"},{"key":"BFonc2015264_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.cmet.2011.04.004","volume":"13","author":"R Singh","year":"2011","unstructured":"Singh R, Cuervo A . Autophagy in the cellular energetic balance. Cell Metab 2011; 13: 495\u2013504.","journal-title":"Cell Metab"},{"key":"BFonc2015264_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.ccr.2011.03.012","volume":"19","author":"JH Sheen","year":"2011","unstructured":"Sheen JH, Zoncu R, Kim D, Sabatini D . Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 2011; 19: 613\u2013628.","journal-title":"Cancer Cell"},{"key":"BFonc2015264_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2353\/ajpath.2008.061263","volume":"172","author":"C Stock","year":"2008","unstructured":"Stock C, Bozsaky E, Watzinger F, Poetschger U, Orel L, Lion T et al. Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization. Am J Pathol 2008; 172: 203\u2013214.","journal-title":"Am J Pathol"},{"key":"BFonc2015264_CR33","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/ncomms2400","volume":"4","author":"S Saita","year":"2013","unstructured":"Saita S, Shirane M, Nakayama KI . Selective escape of proteins from the mitochondria during mitophagy. Nat Commun 2013; 4: 1410.","journal-title":"Nat Commun"},{"key":"BFonc2015264_CR34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1089\/ars.2011.4407","volume":"17","author":"I Novak","year":"2012","unstructured":"Novak I . Mitophagy: a complex mechanism of mitochondrial removal. Antioxid Redox Signal 2012; 17: 794\u2013802.","journal-title":"Antioxid Redox Signal"},{"key":"BFonc2015264_CR35","doi-asserted-by":"publisher","first-page":"e5701","DOI":"10.1371\/journal.pone.0005701","volume":"4","author":"A Sandebring","year":"2009","unstructured":"Sandebring A, Thomas KJ, Beilina A, Beilina AF, van der Brug M, Cleland MM et al. Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLos One 2009; 4: e5701.","journal-title":"PLos One"},{"key":"BFonc2015264_CR36","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1074\/jbc.M407724200","volume":"280","author":"A Yamamoto","year":"2005","unstructured":"Yamamoto A, Friedlein A, Imai Y, Takahashi R, Kahle PJ, Haass C . Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity. J Biol Chem 2005; 280: 3390\u20133399.","journal-title":"J Biol Chem"},{"key":"BFonc2015264_CR37","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4161\/cbt.9.11.11632","volume":"9","author":"D Shutt","year":"2010","unstructured":"Shutt D, O'Dorisio MS, Aykin-Burns N, Spitz D . 2-Deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells. Cancer Biol Ther 2010; 9: 853\u2013861.","journal-title":"Cancer Biol Ther"},{"key":"BFonc2015264_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40259-013-0058-x","volume":"28","author":"B Groner","year":"2014","unstructured":"Groner B, Weiss A . Targeting survivin in cancer: novel drug development approaches. BioDrugs 2014; 28: 27\u201339.","journal-title":"BioDrugs"},{"key":"BFonc2015264_CR39","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1182\/blood-2011-04-351239","volume":"118","author":"E Park","year":"2011","unstructured":"Park E, Gang EJ, Hsieh YT, Schaefer P, Chae S, Klemm L et al. Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood 2011; 118: 2191\u20132199.","journal-title":"Blood"},{"key":"BFonc2015264_CR40","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004; 351: 2817\u20132826.","journal-title":"N Engl J Med"},{"key":"BFonc2015264_CR41","doi-asserted-by":"publisher","first-page":"16259","DOI":"10.1073\/pnas.1113884108","volume":"108","author":"C Zhang","year":"2011","unstructured":"Zhang C, Lin M, Wu R, Wang X, Yang B, Levine AJ et al. Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci 2011; 108: 16259\u201316264.","journal-title":"Proc Natl Acad Sci"},{"key":"BFonc2015264_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.nbd.2006.10.007","volume":"25","author":"HH Hoepken","year":"2007","unstructured":"Hoepken HH, Gispert S, Morales B, Wingerter O, Del Turco D, M\u00fclsch A et al. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis 2007; 25: 401\u2013411.","journal-title":"Neurobiol Dis"},{"key":"BFonc2015264_CR43","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/cdd.2009.200","volume":"17","author":"S Michiorri","year":"2010","unstructured":"Michiorri S, Gelmetti V, Giarda E, Lombardi F, Romano F, Marongiu R et al. The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ 2010; 17: 962\u2013974.","journal-title":"Cell Death Differ"},{"key":"BFonc2015264_CR44","doi-asserted-by":"publisher","first-page":"8581","DOI":"10.1038\/sj.onc.1207113","volume":"22","author":"DC Altieri","year":"2003","unstructured":"Altieri DC . Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581\u20138589.","journal-title":"Oncogene"},{"key":"BFonc2015264_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/jmg.2005.034686","volume":"43","author":"H Caldas","year":"2006","unstructured":"Caldas H, Holloway MP, Hall BM, Qualman SJ, Altura RA . Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo. J Med Genet 2006; 43: 119\u2013128.","journal-title":"J Med Genet"},{"key":"BFonc2015264_CR46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ymthe.2004.05.006","volume":"10","author":"H Uchida","year":"2004","unstructured":"Uchida H, Tanaka T, Sasaki K, Kato K, Dehari H, Ito Y et al. Adenovirus-mediated transfer of sirna against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther 2004; 10: 162\u2013171.","journal-title":"Mol Ther"},{"key":"BFonc2015264_CR47","doi-asserted-by":"publisher","first-page":"8014","DOI":"10.1158\/0008-5472.CAN-07-1343","volume":"67","author":"T Nakahara","year":"2007","unstructured":"Nakahara T, Takeuchi M, Kinoyama I, Minematsu T, Shirasuna K, Matsuhisa A et al. YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res 2007; 67: 8014\u20138021.","journal-title":"Cancer Res"},{"key":"BFonc2015264_CR48","doi-asserted-by":"publisher","first-page":"13239","DOI":"10.1073\/pnas.0405407101","volume":"101","author":"CC Chang","year":"2004","unstructured":"Chang CC, Heller JD, Kuo J, Huang RC . Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression. Proc Natl Acad Sci USA 2004; 101: 13239\u201313244.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015264_CR49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijrobp.2008.02.011","volume":"71","author":"F R\u00f6del","year":"2008","unstructured":"R\u00f6del F, Frey B, Leitmann W, Capalbo G, Weiss C, R\u00f6del C . Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models. Int J Radiat Oncol Biol Phys 2008; 71: 247\u2013255.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFonc2015264_CR50","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00262-005-0102-x","volume":"55","author":"M Wobser","year":"2006","unstructured":"Wobser M, Keikavoussi P, Kunzmann V, Weininger M, Andersen M, Becker J . Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin. Cancer Immunol Immunother 2006; 55: 1294\u20131298.","journal-title":"Cancer Immunol Immunother"},{"key":"BFonc2015264_CR51","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/annonc\/mdr353","volume":"23","author":"AW Tolcher","year":"2012","unstructured":"Tolcher AW, Quinn DI, Ferrari A, Ahmann F, Giaccone G, Drake T et al. A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer. Ann Oncol 2012; 23: 968\u2013973.","journal-title":"Ann Oncol"},{"key":"BFonc2015264_CR52","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1158\/1078-0432.CCR-08-1946","volume":"15","author":"T Satoh","year":"2009","unstructured":"Satoh T, Okamoto I, Miyazaki M, Morinaga R, Tsuya A, Hasegawa Y et al. Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors. Clin Cancer Res 2009; 15: 3872\u20133880.","journal-title":"Clin Cancer Res"},{"key":"BFonc2015264_CR53","doi-asserted-by":"publisher","first-page":"11480","DOI":"10.1073\/pnas.0500303102","volume":"102","author":"S Gurbuxani","year":"2005","unstructured":"Gurbuxani S, Xu Y, Keerthivasan G, Wickrema A, Crispino JD . Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci USA 2005; 102: 11480\u201311485.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015264_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1084\/jem.20031588","volume":"199","author":"Z Xing","year":"2004","unstructured":"Xing Z, Conway EM, Kang C, Winoto A . Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med 2004; 199: 69\u201380.","journal-title":"J Exp Med"},{"key":"BFonc2015264_CR55","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0002-9440(10)64131-4","volume":"158","author":"M Mesri","year":"2001","unstructured":"Mesri M, Morales-Ruiz M, Ackermann EJ, Bennett CF, Pober JS, Sessa WC et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol 2001; 158: 1757\u20131765.","journal-title":"Am J Pathol"},{"key":"BFonc2015264_CR56","first-page":"2683","volume":"9","author":"OP Blanc-Brude","year":"2003","unstructured":"Blanc-Brude OP, Mesri M, Wall NR, Plescia J, Dohi T, Altieri DC . Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 2003; 9: 2683\u20132692.","journal-title":"Clin Cancer Res"},{"key":"BFonc2015264_CR57","doi-asserted-by":"publisher","first-page":"13791","DOI":"10.1073\/pnas.2434345100","volume":"100","author":"P Fortugno","year":"2003","unstructured":"Fortugno P, Beltrami E, Plescia J, Fontana J, Pradhan D, Marchisio PC et al. Regulation of survivin function by Hsp90. Proc Natl Acad Sci 2003; 100: 13791\u201313796.","journal-title":"Proc Natl Acad Sci"},{"key":"BFonc2015264_CR58","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ccr.2005.03.035","volume":"7","author":"J Plescia","year":"2005","unstructured":"Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG et al. Rational design of shepherdin, a novel anticancer agent. Cancer Cell 2005; 7: 457\u2013468.","journal-title":"Cancer Cell"},{"key":"BFonc2015264_CR59","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1182\/blood.V100.7.2463","volume":"100","author":"SF Fukuda","year":"2002","unstructured":"Fukuda SF . The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34+ cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 2002; 100: 2463\u20132471.","journal-title":"Blood"},{"key":"BFonc2015264_CR60","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jpedsurg.2014.01.037","volume":"49","author":"JF Bean","year":"2014","unstructured":"Bean JF, Qiu YY, Yu S, Clark S, Chu F, Madonna MB . Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma. J Pediatr Surg 2014; 49: 981\u2013984.","journal-title":"J Pediatr Surg"},{"key":"BFonc2015264_CR61","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.biocel.2013.01.019","volume":"45","author":"JH Chuang","year":"2013","unstructured":"Chuang JH, Chou MH, Tai MH, Lin TK, Liou CW, Chen T et al. 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth. Int J Biochem Cell Biol 2013; 45: 944\u2013951.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFonc2015264_CR62","first-page":"14","volume":"58","author":"F Grignani","year":"1998","unstructured":"Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F et al. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV\/retroviral vector expressing the green fluorescence protein. Cancer Res 1998; 58: 14\u201319.","journal-title":"Cancer Res"},{"key":"BFonc2015264_CR63","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1158\/1535-7163.MCT-05-0500","volume":"5","author":"MJ Ausserlechner","year":"2006","unstructured":"Ausserlechner MJ, Obexer P, Deutschmann A, Geiger K, Kofler R . A retroviral expression system based on tetracycline-regulated tricistronic transactivator\/repressor vectors for functional analyses of anti-proliferative and toxic genes. Mol Cancer Ther 2006; 5: 1927\u20131934.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2015264_CR64","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1242\/jcs.092098","volume":"125","author":"J Hagenbuchner","year":"2012","unstructured":"Hagenbuchner J, Kuznetsov A, Hermann M, Hausott B, Obexer P, Ausserlechner MJ . FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci 2012; 125: 1191\u20131203.","journal-title":"J Cell Sci"},{"key":"BFonc2015264_CR65","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1091\/mbc.e11-06-0535","volume":"23","author":"K Geiger","year":"2012","unstructured":"Geiger K, Hagenbuchner J, Rupp M, Fiegl H, Sergi C, Meister B et al. FOXO3\/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma. Mol Biol Cell 2012; 23: 2226\u20132234.","journal-title":"Mol Biol Cell"},{"key":"BFonc2015264_CR66","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1074\/jbc.M109.038331","volume":"285","author":"J Hagenbuchner","year":"2010","unstructured":"Hagenbuchner J, Ausserlechner MJ, Porto V, David R, Meister B, Bodner M et al. The anti-apoptotic protein BCL2L1\/Bcl-xL is neutralized by pro-apoptotic PMAIP1\/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. J Biol Chem 2010; 285: 6904\u20136912.","journal-title":"J Biol Chem"},{"key":"BFonc2015264_CR67","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.18632\/oncotarget.1147","volume":"4","author":"J Hagenbuchner","year":"2013","unstructured":"Hagenbuchner J, Kiechl-Kohlendorfer U, Obexer P, Ausserlechner MJ . A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration. Oncotarget 2013; 4: 1241\u20131252.","journal-title":"Oncotarget"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2015264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015264","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:17:40Z","timestamp":1647893860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2015264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":67,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,4,21]]}},"alternative-id":["BFonc2015264"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.264","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]},"assertion":[{"value":"3 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}